Lack of access to antibiotics is a key driver of antimicrobial resistance

  30 November 2022

Sustainable access to antibiotics in low- and middle-income countries is crucial. 

A recent webinar during the World Antimicrobial Awareness Week brought up one of the important factors driving up antimicrobial resistance — access to antibiotics, specially first-line treatments.

When bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, it makes infections harder to treat. This increases the risk of disease spread, severe illness and death, also known as antimicrobial resistance (AMR).

AMR phenomenon leads to deaths, morbidity, high treatment cost, increased hospital stays and also losses in animal productivity and economic and livelihood losses. It was responsible for approximately 5 million deaths in 2019, according to a recent study.

Further reading: Down to Earth
Author(s): Gauri Arora
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed